Cabot Corporation (NYSE:CBT) Sees Significant Drop in Short Interest

Cabot Corporation (NYSE:CBT) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 1,620,000 shares, a decrease of 26.7% from the September 30th total of 2,210,000 shares. Approximately 3.1% of the company’s shares are sold short. Based on an average daily trading volume, of 384,500 shares, the days-to-cover ratio is currently 4.2 days. Based on an average daily trading volume, of 384,500 shares, the days-to-cover ratio is currently 4.2 days. Approximately 3.1% of the company’s shares are sold short.

Insider Buying and Selling at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. This represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 3.03% of the company’s stock.

Hedge Funds Weigh In On Cabot

Institutional investors have recently made changes to their positions in the company. Beverly Hills Private Wealth LLC grew its position in Cabot by 3.6% during the first quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company’s stock valued at $326,000 after buying an additional 135 shares during the period. Keeley Teton Advisors LLC boosted its stake in shares of Cabot by 1.0% during the 1st quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company’s stock worth $1,393,000 after acquiring an additional 174 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Cabot by 1.7% during the 2nd quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company’s stock worth $791,000 after acquiring an additional 181 shares in the last quarter. Isthmus Partners LLC grew its position in shares of Cabot by 4.6% during the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company’s stock valued at $354,000 after acquiring an additional 186 shares during the period. Finally, Parkside Financial Bank & Trust increased its stake in shares of Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after purchasing an additional 189 shares in the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CBT shares. Mizuho reduced their target price on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research note on Friday, October 3rd. UBS Group set a $82.00 price objective on shares of Cabot and gave the company a “neutral” rating in a report on Tuesday, August 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $85.00.

Cabot Price Performance

Shares of CBT opened at $61.56 on Wednesday. The business’s 50-day moving average is $74.73 and its two-hundred day moving average is $75.88. The company has a market capitalization of $3.27 billion, a P/E ratio of 8.05 and a beta of 0.88. Cabot has a fifty-two week low of $61.18 and a fifty-two week high of $117.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The company had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The firm’s quarterly revenue was down 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts predict that Cabot will post 7.57 earnings per share for the current year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.